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ABSTRACT We analyzed the 16S rRNA amplicon composition in fecal samples of selected patients during their prolonged stay in
an intensive care unit (ICU) and observed the emergence of ultra-low-diversity communities (1 to 4 bacterial taxa) in 30% of the
patients. Bacteria associated with the genera Enterococcus and Staphylococcus and the family Enterobacteriaceae comprised the
majority of these communities. The composition of cultured species from stool samples correlated to the 16S rRNA analysis and
additionally revealed the emergence of Candida albicans and Candida glabrata in ~75% of cases. Four of 14 ICU patients har-
bored 2-member pathogen communities consisting of one Candida taxon and one bacterial taxon. Bacterial members displayed
a high degree of resistance to multiple antibiotics. The virulence potential of the 2-member communities was examined in
C. elegans during nutrient deprivation and exposure to opioids in order to mimic local conditions in the gut during critical ill-
ness. Under conditions of nutrient deprivation, the bacterial members attenuated the virulence of fungal members, leading to a
“commensal lifestyle.” However, exposure to opioids led to a breakdown in this commensalism in 2 of the ultra-low-diversity
communities. Application of a novel antivirulence agent (phosphate-polyethylene glycol [Pi-PEG]) that creates local phosphate
abundance prevented opioid-induced virulence among these pathogen communities, thus rescuing the commensal lifestyle. To
conclude, the gut microflora in critically ill patients can consist of ultra-low-diversity communities of multidrug-resistant
pathogenic microbes. Local environmental conditions in gut may direct pathogen communities to adapt to either a commensal
style or a pathogenic style.
IMPORTANCE During critical illness, the normal gut microbiota becomes disrupted in response to host physiologic stress and
antibiotic treatment. Here we demonstrate that the community structure of the gut microbiota during prolonged critical illness
is dramatically changed such that in many cases only two-member pathogen communities remain. Most of these ultra-low-
membership communities display low virulence when grouped together (i.e., a commensal lifestyle); individually, however, they
can express highly harmful behaviors (i.e., a pathogenic lifestyle). The commensal lifestyle of the whole community can be
shifted to a pathogenic one in response to host factors such as opioids that are released during physiologic stress and critical ill-
ness. This shift can be prevented by using compounds such as Pi-PEG15-20 that interrupt bacterial virulence expression. Taking
the data together, this report characterizes the plasticity seen with respect to the choice between a commensal lifestyle and a
pathogenic lifestyle among ultra-low-diversity pathogen communities that predominate in the gut during critical illness and
offers novel strategies for prevention of sepsis.
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The gastrointestinal tract reservoir is the primary site of coloni-zation of health care-associated pathogens and the site from
which most pathogens disseminate to cause serious infections (1–
5). In addition, the intestinal tract has been considered to be the
key site for the emergence of antibiotic resistance and virulence
expression among health care-associated pathogens that ulti-
mately cause life-threatening sepsis (6–8). This situation is espe-
cially prevalent during prolonged critical illness, when the gut
undergoes nearly complete ecological collapse owing to the selec-
tive pressures imposed by modern intensive care therapy, includ-
ing multiple antibiotic exposure, provision of all nutrients exclu-
sively through the intravenous route (total parenteral nutrition),
and the use of vasoactive agents that alter the intestinal blood
supply, acid-reducing agents, and opioids. As a result, a syndrome
of gut-derived sepsis can be observed to occur late in the course of
critical illness as microbes struggle to survive. Emergence of anti-
RESEARCH ARTICLE crossmark
September/October 2014 Volume 5 Issue 5 e01361-14 ® mbio.asm.org 1
biotic resistance under such circumstances is proposed to occur in
the gut due to these aggregate selective pressures. Thus, the term
“late-onset sepsis” is being used to describe sepsis late in the
course of critical illness involving multidrug-resistant (MDR)
health care-acquired pathogens (9–14). A better understanding of
the ecological perturbations that develop in the microbiota during
critical illness, in terms of both composition and function, is cru-
cial to prevent late-onset sepsis during the often-unanticipated
prolonged course of recovery from extreme medical interventions
such as organ transplant, cancer chemotherapy, and burn injury.
Here we characterized the composition and function of micro-
bial communities from several sets of fecal samples from patients
suffering from prolonged critical illness. Our results indicate that
prolonged critical illness results in near-complete disruption of
FIG 1 The taxonomic composition of the gut microbiome at the phylum level determined by 16S rRNA analysis of stool samples collected from healthy
volunteers (A), ICU patients dying with signs of severe sepsis (as indicated by black circles on the time line) (B), and ICU patients who had recovered (as indicated
by green circles on the time line) (C). Dates of stool collection are displayed in numbered quadrants.
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the normal microbiota, the members of which are replaced by
ultra-low-diversity communities of highly resistant pathogens
whose virulent or nonvirulent behavior is dependent on the inter-
actions between its members and provocative host factors (i.e.,
opioids). A more complete understanding of the threat of highly
virulent and resistant pathobiomes that emerge as members of the
normal microbiota disappear over the course of prolonged critical
illness is warranted to develop new strategies to prevent late-onset
sepsis in hospitalized patients.
RESULTS
16S rRNA analysis of the bacterial composition in stool samples
of ICU patients. (i) Phylum level. Stool samples from healthy
volunteers demonstrated dominance of Firmicutes and Bacte-
roidetes among the four stool samples (H1, H2, H4, and H5). A
predominance of Firmicutes and very low levels of Bacteroidetes
were found in one (H3) stool sample. Proteobacterial abundance
remained below 1% in healthy volunteers (Fig. 1A). In 50% of
intensive care unit (ICU) patients (ICU1, ICU4, ICU6, ICU9,
ICU11, and ICU15), either Proteobacteria or Firmicutes organisms
were totally dominant from at least one time point of stool collec-
tion (Fig. 1B and C). In patients ICU1, ICU11, and ICU15, during
their course of hospitalization, we observed dramatic changes in
microbial composition, withFirmicutesbeing completely replaced
by Proteobacteria. Proteobacteria-dominated communities that
persisted during the course of hospitalization were found in the
stool samples of patients ICU6 (Fig. 1B) and ICU4 (Fig. 1C). Im-
portantly, Proteobacteria and Firmicutes dominated in the stool of
both deceased (Fig. 1B) and discharged (Fig. 1C) ICU patients.
(ii) Genus level. In the group of healthy volunteers, the
microbial communities comprised ~40 bacterial genera (see
Fig. S1 in the supplemental material), including Coprococcus
(phylum Firmicutes [p_Firmicutes], family Lachnospiraceae
[f_Lachnospiraceae]), Bacteroides (p_Bacteroidetes, f_Bacte-
roidaceae), Roseburia (p_Firmicutes, f_Lachnospiraceae),
Prevotella (p_Bacteroidetes, f_Prevotellaceae), a nonidentified ge-
nus of f_Lachnospiraceae (p_Firmicutes), a nonidentified genus of
f_Coprobacillaceae (p_Firmicutes), and Blautia (p_Firmicutes,
f_Lachnospiraceae) as the seven most abundant. The microbial
composition in critically ill patients was profoundly different
from that in healthy volunteers. We observed decreased diversity
in80% ICU stool samples as seen by Chao1 index values below
50 and extremely low diversity in ~50% of ICU stool samples as
seen by Chao1 diversity index values below 10 (Fig. 2). Unusually
high abundances of Pseudomonadaceae were observed in the stool
of ICU2 and ICU3 (10% and 30%, respectively) (see Fig. S2).
Decreased diversity and domination by Escherichia and Enterococ-
cus were found in seven patients (ICU5, ICU8, ICU10, and ICU12
to ICU15) (see Fig. S3).
The emergence of extremely low bacterial diversity (90%
abundance of one bacterial taxon) was determined in samples
from five patients (ICU1, ICU4, ICU6, ICU9, and ICU11) (Fig. 3;
see also Fig. S4 in the supplemental material). A predominance
(90% abundance) of Enterococcus (p_Firmicutes, f_Enterococ-
caceae), Staphylococcus (p_Firmicutes, f_Staphylococcaceae), and
f_Enterobacteriaceae with an absence of p_Bacteroidetes was the
most striking feature of this group. Another striking feature of this
group was fast dynamic replacement of one dominated phylum by
another (i.e., Firmicutes by Proteobacteria). The taxonomic com-
position in the microbiomes in the members of these groups was
found to be similar to the composition of cultured bacteria (Fig. 3;
see also Fig. S4), a unique situation that may develop only when
the microbiome diversity is profoundly decreased. We also no-
ticed the presence of the eukaryotic pathogen Candida in four of
five patients. One of the five patients (ICU9, who was discharged
after 10 days in the ICU) did not harbor Candida species. Reads
corresponding toEnterococcus determined by 16S rRNA amplicon
sequencing in the stool of ICU9 comprised 98.82% of all sequence
reads and represented 2 cultivable Enterococcus species, MDR
E. faecium and E. gallinarum (see Fig. S4). Blood cultures from this
patient yielded Escherichia coli but were culture negative for En-
terococcus. The other 4 patients (ICU1, ICU4, ICU6, and ICU11)
were admitted to the ICU for longer than a month; for these pa-
tients, a temporal series of stool samples were acquired. Thus, we
could correlate the 16S rRNA amplicon profiles with the clinical
histories, antibiotic therapy, and microbiological culture data
from nongastrointestinal sources (i.e., blood, sputum, and urine)
and gastrointestinal sources (feces) for each of these patients
(Fig. 3).
The 16S rRNA profiling is in agreement with culture analysis
of stool samples in ICU patients harboring low-diversity patho-
gen communities. (i) Patient ICU1 (Fig. 3A). Patient ICU1 was
admitted for a liver transplant but died from severe sepsis before
undergoing transplantation following 8 weeks of ICU confine-
ment. In this patient’s stool sample collected at time point 1 (i.e.,
ICU1-1), Enterococcus reads comprised 99.9% of the 16S rRNA
sequenced reads. Culture analysis of the first stool samples
(ICU1-1) presented a 2-member community of MDR E. faecium
and Candida albicans. A retrospective analysis of the clinical his-
tory of this patient demonstrated that the urine and paracentesis
fluid of this patient were culture positive for C. albicans and E. fae-
cium (Fig. 3A). In the second stool sample (ICU1-2) taken 23 days
later, Enterobacteriaceae and Enterococcus reads comprised 96%
and 3.3% of the 16S rRNA reads, respectively. Culture results from
the feces demonstrated a 4-member community consisting of
MDR Serratia marcescens, MDR Klebsiella oxytoca, tetracycline-
FIG 2 Chao1 diversity index of bacterial composition in fecal samples. Chao1
index values for stool samples of healthy volunteers (black circles) and ICU
patients (colored circles) are ordered as follows (left to right): 1 to 5, healthy
volunteers; 6 and 7, ICU1-1 and ICU1-2; 8 to 11, ICU2-1 to ICU2-4; 12 to 15,
ICU3-1 to ICU3-4; 16 to 19, ICU4-1 to ICU4-4; 20, ICU5-1; 21 and 22, ICU6-1
and ICU6-2; 23, ICU8-1; 24, ICU9-1; 25, ICU10-1; 26 to 30, ICU11-1 to
ICU11-5; 31, ICU12-1; 32, ICU13-1; 33, ICU14-1; and 34 and 35, ICU15-1 and
ICU15-2. The horizontal dashed lines corresponding to Chao1 index values
50 and10 represent arbitrary cutoffs. For the samples in this study, 14 had
Chao1 index values of10, 12 had Chao1 index values of 10 to 15, and 9 had
Chao1 index values of50. Mean Chao1 index value, 33; median, 25; range,
1.46 to 100.24.
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resistant (Tetr) E. faecalis, and C. albicans. At that time, the urine
and blood of the patient were culture positive for C. albicans and
Enterococcus. The bacterial members of pathogen communities
were found to be resistant to multiple antibiotics (Fig. 3A). A
retrospective analysis of the clinical history demonstrated that an-
tibiotics were aggressively administered to treat the presumed in-
fection with combinations of up to six antibiotics administered
daily. C. albicans was sensitive to the fungal antibiotics used, but
FIG 3 Taxonomic and culturing composition of 2-member pathogen communities in correlation to antibiotic regimen, antibiotic resistance of stool isolates,
and microbial data of cultured species from nonintestinal samples. (A) Patient ICU1. (B) Patient ICU6. (C) Patient ICU11. (D) Patient ICU4. Cultured species
from sources other than the gut refer to species cultured from extraintestinal sources such as blood, urine, and lung. The arrows indicate the time points along
the course of antibiotic exposure at which these organisms were cultured. Vanc, vancomycin; cipro, ciprofloxacin; difluca, fluconazole (Diflucan); AmphoB,
amphotericin B; flagyl, metronidazole (Flagyl); Pip, piperacillin; TMP/SUX, trimethoprim/sulfamethoxazole; Quinupristin/dalf, quinupristin/dalfopristin;
Staph, Staphylococcus.
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the bacteria present were resistant to several of the antibiotics
used, including ciprofloxacin, piperacillin-tazobactam (Zosyn),
and linezolid. The observation that microbial pathogens persisted
in the gut suggests that they might have been a continuing source
of infection.
(ii) Patient ICU6 (Fig. 3B). Patient ICU6 was transferred from
an outside hospital, where he was treated for a presumed pneu-
monia without any improvement. He was suspected of having a
postprocedure esophageal perforation. The patient was placed on
broad-spectrum antibiotics during his hospital stay because of
mediastinitis and bilateral empyema. Throughout his stay,
methicillin-resistant Staphylococcus aureus (MRSA) was cultured
from his sputum as well as from his chest tube sites bilaterally and
from his pleural fluid, and he eventually died of severe sepsis. Two
stool samples (ICU6-1 and ICU6-2) collected 25 days apart were
analyzed using 16S rRNA amplicon sequencing. In sample
ICU6-1, 86.83% of sequence reads showed the presence of Enter-
obacteriaceae, while 12.9% showed the presence of Staphylococcus;
these were confirmed by culture to represent K. pneumoniae and
methicillin-resistant S. aureus. In sample ICU6-2, 97.78% of the
16S rRNA reads indicated the presence of Enterobacteriaceae,
which was in agreement with culture results indicating that the
reads exclusively represented K. pneumoniae. The eukaryotic
pathogen C. albicans was cultured in both stool samples (ICU6-1
and ICU6-2). Despite the sensitivity to fluconazole, C. albicans
persisted in the gut of patient ICU6 throughout treatment with
FIG 3 (Continued)
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multiple fungal antibiotics, including fluconazole. K. pneumoniae
was found to produce extended-spectrum beta-lactamase, defin-
ing it as strain ESBL, and also to be resistant to multiple antibiot-
ics. It was sensitive, however, to tobramycin and imipenem, but
despite the patient being treated with these antibiotics, K. pneu-
moniae ESBL persisted in his gut during his ICU stay. C. albicans,
MRSA, and K. pneumoniae were cultured from the pleural fluid
and tracheal aspirates over the course of hospitalization in patient
ICU6.
(iii) Patient ICU11 (Fig. 3C). Patient ICU11 suffered from in-
testinal bleeding, requiring several operations to control the
bleeding. The patient had several underlying comorbidities, in-
cluding a nonischemic cardiomyopathy. Following the last oper-
ation, the patient developed progressive decompensation and
multiorgan system failure and eventually died from severe sepsis
after being confined to the ICU for 2 months. Stool samples were
collected at 5 time points (Fig. 3C). ICU11-1 and ICU11-2 16S
rRNA reads indicated 89.7% and 99.4% levels of Staphylococcus,
respectively, which was in agreement with culturing analyses
yielding only coagulase-negative (CoA) staphylococcus. Stool
samples ICU11-3 and ICU11-4 demonstrated the presence of En-
terobacteriaceae, corresponding to 99.26% and 94.98% of se-
FIG 3 (Continued)
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quence reads, respectively, which was in agreement with culture
identifying K. pneumoniae. Later in the course of the patient’s
illness (ICU 11-5), coagulase-negative staphylococci emerged
again. The eukaryotic pathogen Candida glabrata persisted at all
points of stool collections from this patient. CoA Staphylococcus,
K. pneumoniae, and C. glabrata were cultured from blood and
urine at various times during the course of ICU confinement.
Similarly to the cases described above, the gut microbial patho-
gens persisted regardless of their sensitivity or resistance to anti-
biotics applied to the patient.
(iv) Patient ICU4 (Fig. 3D). Patient ICU4 was the only patient
of the four with ultra-low-diversity pathogen communities who
survived and was discharged after 40 days in the ICU. This patient
was admitted to the ICU with a history of anaplastic astrocytoma,
including 2 weeks of decreased oral intake, altered mental status,
and fevers. The analysis of four stool collections at various time
points (Fig. 3D) demonstrated the persistence of the same com-
position microbial community dominated by Enterobacteriaceae,
comprising 99.8% to 99.9% of the 16S rRNA sequences, which
was in agreement with the culture results showing the presence of
Enterobacter aerogenes resistant to multiple antibiotics. Addition-
ally, the eukaryotic pathogen C. albicans was persistently cultured
from feces of patient ICU4 during the ICU stay. C. albicans was
found to be sensitive to fluconazole andE. aerogenes to be sensitive
FIG 3 (Continued)
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to piperacillin-tazobactam and imipenem—antibiotics with
which the patient was treated. Despite the sensitivity to these an-
tibiotics, the community comprising C. albicans plus E. aerogenes
persisted during this course of treatment (Fig. 3D). E. aerogenes
was recovered from the bronchoalveolar lavage samples and en-
dotracheal aspirates of this patient.
To conclude, in all cases listed above (ICU1, ICU4, ICU6, and
ICU11), there were similar striking features that included a strong
agreement of 16S rRNA amplicon sequencing profiles with the
bacterial composition shown by culture, an agreement of the re-
sults determined using microbes cultured from intestinal and
nonintestinal sources, and a failure of aggressive antibiotic treat-
ment to eliminate these pathogens regardless of their sensitivities
to administered antibiotics. Antibiotic susceptibilities of all the
cultured microbes from the patients in this study are displayed in
Table S1 in the supplemental material. As might be predicted, a
high frequency of antibiotic-resistant microorganisms colonizing
the gut of critically ill patients was observed.
Ex vivo analysis of potential virulence of low-diversity intes-
tinal communities. Given the close correlation of 16S rRNA am-
plicon sequencing profiles to microbial composition revealed by
culture, we decided to determine the virulence potential of these
pathogen communities by reassembling them ex vivo and allowing
C. elegans to feed on them. C. elegans normally feeds on bacteria as
a food source, and therefore its response to pathogen communi-
ties can be viewed as a proxy for the virulence potential of the
bacterium. Six communities were included in the analysis:
ICU1-1 (C. albicans: Enterococcus faecium), ICU6-2 (C. albicans:
Klebsiella pneumoniae), ICU4-4 (C. albicans: Enterobacter aero-
genes), ICU11-2 (C. glabrata: CoA Staphylococcus), ICU11-4
(C. glabrata: K. pneumoniae), and ICU9-1 (Enterococcus faecium:
Enterococcus gallinarum). Based on results of C. elegans experi-
ments, we made several important observations recorded below.
(i) Commensal lifestyle of 2-member pathogen communi-
ties. In the first round of the experiments, to mimic the nutrient-
limited environment typical of the gut of a critically ill host, we
FIG 4 The commensal behavior of the 2-member pathogen communities. Data represent Kaplan-Meier survival curves ofC. elegans fed on 2-member pathogen
communities and their individual members (n 10/plate, 3 plates/group). Data represent the cumulative results of 2 experiments.
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grew the individual members of the communities as well as assem-
bled whole communities in nutrient-poor 0.1 TY liquid media
(tryptone, 1 g/liter; yeast extract, 0.5 g/liter, potassium phosphate
buffer, 0.1 mM [pH 6.0]) (referred to here as 0.1 TY). After 4 h
of growth in 0.1 TY, prestarved and antibiotic-treated worms
were transferred to the microbial cultures. Antibiotic treatment
was used to eliminate all residual bacteria from the intestinal tubes
of the worms. We found that all but one Candida species (C. albi-
cans ICU4-4) caused high levels of mortality in C. elegans (Fig. 4).
None of the individual bacteria demonstrated a high killing capac-
ity, and they were able to attenuate the C. elegans mortality caused
by the Candida species, resulting in a commensal assemblage.
(ii) Replacement of a comember can switch commensal or-
ganisms to display pathogenic behavior. As seen in Fig. 5, the
killing ability of the ICU1-2 community significantly exceeded the
killing ability of the ICU1-1 community. This correlated with the
morphology of C. albicans inside the community, with the yeast
form being prevalent in the ICU1-1 sample and the hyphal form
being prevalent in the ICU1-2 sample. These data confirm our
previous demonstration that the ICU1-2 community consisting of
C. albicans plus S. marcescens plus K. oxytoca plus E. faecalis in-
duces a high level of mortality in C. elegans and mouse models
(15). Therefore, the sudden replacement of a comember may pro-
voke pathogenic behavior in a newly created community.
(iii) Critical care therapy can break commensalism. As was
previously demonstrated, critical care factors used for treatment
of critically ill patients (i.e., steroids, hormones, and opioids) can
induce bacterial virulence via interkingdom signaling through
their interaction with quorum-sensing signaling systems (15–23).
Opioids can also be released in the gut during physiological stress
such as that seen following ischemia, which commonly occurs
during critical illness (16). To determine if host-derived factors
can affect the commensalism, we included a synthetic opioid (U-
50,488) in the growth media. We have previously shown that this
potent ligand of the kappa-opioid receptor acts similarly to the
endogenous kappa-opioid dynorphin (16), which is released dur-
ing intestinal ischemia. C. elegans was allowed to feed on bacteria
grown under conditions of nutrient limitation (0.1 TY) and
exposure to opioids (50 M of U-50,488). In two communities,
ICU6-2 and ICU11-2, the addition of 50 M U-50,488 signifi-
cantly increased the killing capacity of bacterial members K. pneu-
moniae ICU6-2 and CoA Staphylococcus ICU11-2; accordingly,
the virulence of each assemblage was shifted from a commensal
behavior to a pathogenic one (Fig. 6). However, not all the patho-
gen communities responded with enhanced killing capacity dur-
ing opioid exposure. There was no significant increase in the mor-
tality of worms fed on ICU1-1, ICU11-4, ICU4-4, and ICU9-1
communities (Fig. 6; see also Fig. S5 in the supplemental mate-
rial), a result similar to the baseline control of mortality seen with
C. elegans fed on a nonpathogen food source such as E. coli OP 50
(see Fig. S6).
We have summarized the community compositions, their be-
havior in the C. elegans model, and the outcomes of patients in
Table 1. Although this study was not powered to determine if
C. elegans mortality readouts can predict patient outcome, there
appears to be an association between whether a community dis-
plays commensal versus pathogenic behavior and an outcome.
For example, community ICU1-1, which displayed commensal
behavior, became replaced by community ICU1-2, which dis-
played a pathogenic behavior, and this patient died. The prote-
FIG 5 Replacement of bacterial comember switches the commensal behavior to pathogenic. (A) Kaplan-Meier survival curves of C. elegans fed on ICU1-1 and
ICU1-2 pathogen communities (n 10/plate, 3 plates/group). Data represent the cumulative results of 2 experiments. (B and C) Scanning electron microscopy
images of ICU1-1 (B) and ICU1-2 (C) grown for 20 h in 0.1 TY.
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odominant ICU4-4 community displayed commensal behavior
even under provocative conditions (i.e., opioid exposure), and
the patient recovered and was discharged. In patient ICU11,
pathogenic community ICU11-2 (CoA Staphylococcus plus
C. glabrata) was replaced by a nonpathogenic community,
ICU11-4 (K. pneumoniae plus C. glabrata); however, reemergence
of CoA Staphylococcus was observed later, at time point 5
(ICU11-5), and this patient died. These data (although not pow-
ered) do suggest that the development of sepsis may not necessar-
ily be a function of the specific taxa present but rather of whether
the remaining species behave commensally or pathogenically as a
community.
(iv) Phosphate abundance in the form of Pi-PEG can pro-
mote commensalism. Recent work from our laboratory demon-
strated that extracellular phosphate (Pi) regulates bacterial viru-
lence across a wide variety of pathogens (24). When phosphate is
abundant, pathogen virulence is suppressed even in the presence
of opioids; conversely, when phosphate is depleted, virulence ex-
pression is enhanced (17, 25). In order to preserve phosphate
abundance in the gut during physiologic stress in a durable and
bioavailable form, we covalently bound phosphate onto a high-
molecular-weight polyethylene glycol (PEG) carrier compound to
create Pi-PEG (15). We recently reported the efficacy and mech-
anism by which Pi-PEG can attenuate the virulence and lethality
FIG 6 Opioids can break the commensalism of 2-member pathogen communities. Kaplan-Meier survival curves of C. elegans fed on ICU6-2 (A), ICU11-2 (B),
ICU11-4 (C), and ICU4-4 (D) 2-member communities in the presence of an opioid (50 M U-50,488) (n 10/plate, 3 plates/group; P 0.01). Data represent
the cumulative results of 2 experiments. Exposure to opioids broke the commensalism in the ICU6-2 and ICU11-2 communities.
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of highly resistant and virulent intestinal pathogens recovered
from critically ill patients (15). In the current study, synthesized
Pi-PEG15-20 was observed to prevent C. elegans mortality when
C. elegans was feeding on whole communities ICU6-2 and
ICU11-2 during exposure to the opioid compound U-50,488
(Fig. 7).
DISCUSSION
The composition, community structure, and behavior of mi-
crobes that colonize the human gut during prolonged critical ill-
ness remain poorly characterized. Most patients who enter an in-
tensive care unit remain there, on average, 2 to 3 days until they are
stabilized, transferred to the recovery floor, and discharged to
home. However, the members of the gut microbiota of a patient
confined for a prolonged period in the ICU may be subjected to
unprecedented environmental circumstances where they have to
compete for limited resources and survive under harsh and hostile
conditions. Microbial diversity can be lost and resistance genes
and virulence traits can be selected for as the remaining patho-
genic communities struggle to survive conditions of nutrient de-
privation and exposure to drugs and host compensatory signals.
There exists little information regarding which members of the
pathobiota remain in the gut following prolonged critical illness
and how they function in this hostile microenvironment. Advan-
tages in next-generation sequencing provide exciting opportuni-
ties to determine the composition of the gut microbiome in indi-
vidual patients as a “microbial fingerprint.” The challenge,
however, will be to predict the behavior of a given pathogen com-
munity in the context of altering the clinical course of the patient.
Here we found that critically ill patients subjected to prolonged
confinement in the ICU can harbor multidrug-resistant ultra-
low-diversity microbial communities consisting of 2 to 4 patho-
gens whose individual virulence capacities are dependent on their
composition and ability to respond to compensatory host factors
released during stress. Candida albicans was the most prevalent
and most stable member in 2-member pathogen communities
despite patients being treated with a variety of antifungals to
which it was susceptible. Infections due to C. albicans are known
to originate from the gut during critical illness and are a major
cause of late-onset sepsis and mortality in the ICU (26–28).
The C. albicans virulence in the dual communities was found
to be suppressed by the presence of bacterial comembers such as
E. faecium, K. pneumoniae, and CoA Staphylococcus. Such
commensal-like behavior has been recently described by others
for C. albicans and E. faecalis (29, 30), and yet we show that
C. albicans-bacterium commensalism can be disrupted when the
organisms are exposed to opioids, which raises the possibility that
the degree of host stress may play a role in shifting communities
toward a more pathogenic state. We show for the first time that
2-member communities of C. albicans plus bacteria can super-
dominate the normal gut microbiota during prolonged critical
TABLE 1 Compositions of microbial communities, their behavior in the C. elegans model, and patient outcomes
Patient
Time point of





ICU1 1 E. faecium ICU1-1, C. albicans ICU1-1 Commensal Deceased
ICU1 2 E. faecalis ICU1-2, C. albicans ICU1-2, S. marcescens ICU1-2, K. oxytoca ICU1-2 Pathogenic
ICU4 1 E. aerogenes ICU4-1, C. albicans ICU4-1 NTb Discharged
ICU4 2 E. aerogenes ICU4-2, C. albicans ICU4-2 NT
ICU4 3 E. aerogenes ICU4-3, C. albicans ICU4-3 NT
ICU4 4 E. aerogenes ICU4-4, C. albicans ICU4-4 Commensal
ICU6 1 S. aureus ICU6-1, K. pneumoniae ICU6-1, C. albicans ICU6-1 NT Deceased
ICU6 2 K. pneumoniae ICU6-2, C. albicans ICU6-2 Pathogenic
ICU9 1 E. faecium ICU9-1, E. gallinarum ICU9-1 Commensal Discharged
ICU11 1 CoA Staphylococcus ICU11-1, C. glabrata ICU11-1 NT Deceased
ICU11 2 CoA Staphylococcus ICU11-2, C. glabrata ICU11-2 Pathogenic
ICU11 3 K. pneumoniae ICU11-3, C. glabrata ICU11-3 NT
ICU11 4 K. pneumoniae ICU11-4, C. glabrata ICU11-4 Commensal
ICU11 5 CoA Staphylococcus ICU11-5,a K. pneumoniae ICU11-5, C. glabrata ICU11-5 NT
a Note the reemergence of CoA Staphylococcus at time point 5 of stool collection.
b NT, not tested.
FIG 7 Pi-PEG15-20 stabilizes the commensal behavior of 2-member com-
munities. Kaplan-Meier survival curves ofC. elegans fed on ICU6-2 (left panel)
and ICU11-2 (right panel) 2-member communities in the presence of an opi-
oid (50 M U-50,488) with or without 10% Pi-PEG15-20 (n  10/plate, 3
plates/group; P 0.01). Data represent cumulative results of 2 experiments.
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illness. There was strong agreement between 16S rRNA amplicon
profiling and the community composition identified on the basis
of culture, which provided confidence that the cultured commu-
nities could be used ex vivo to understand virulence potential by
usingC. elegansmodels. Previous work in our laboratory has dem-
onstrated that opioids can enter the cytoplasm of bacteria such as
P. aeruginosa and activate their quorum-sensing signaling system,
leading to enhanced virulence (16, 18). Opioids were assessed in
this study because they represent major stress-mediated signaling
compounds in the gut (16, 31–35). The molecular details of the
means by which opioids disrupt commensalism between C. albi-
cans and other bacteria that persist in the gut during critical illness
remain to be elucidated and are likely complex.
We have previously reported the efficacy of Pi-PEG in suppres-
sion of the virulence and lethality of the ICU1-2 community via
mechanisms that involve phosphate-regulated pathways of viru-
lence expression and maintenance of the normal indigenous mi-
crobiota (15). Studies were carried out both in C. elegans and in a
mouse model of lethal gut-derived sepsis. In both C. elegans and
mice, Pi-PEG was highly protective against mortality, and that
protection was due in part to its capacity to create local phosphate
abundance, which attenuates virulence. We had previously shown
that phosphate abundance could prevent virulence of C. albicans
and override the virulence-inducing effect of opioids in P. aerugi-
nosa (17, 25). The present study confirmed that this effect of Pi-
PEG is preserved among multidrug-resistant ultra-low-diversity
pathogen communities.
A major challenge in treating critically ill patients is the overuse
of antibiotics, a practice that is often unavoidable with patients
exposed to multiple invasive procedures and extreme physiologic
stress. A strategy to promote commensalism among the remaining
pathogens by the use of agents such as Pi-PEG, which itself does
not affect bacterial growth, may be useful. For example, data from
the present study suggest that loss of the bacterial partner from a
C. albicans community can derepress its virulence, a possible un-
anticipated consequence of aggressive antibiotic therapy applied
to ICU patients. Our methods and results suggest that such a loss
of these core commensal organisms can be deleterious, especially
when critically ill patients harbor ultra-low-diversity pathogens.
Use of stabilizing agents such as Pi-PEG may offer a mechanism to
preserve commensalism in the gut when aggressive antibiotics are
needed to treat extraintestinal infections.
It is curious that communities that were otherwise seemingly
avirulent (i.e., C. albicans plus Enterobacter aerogenes in patient
ICU4 and E. faecium plus E. gallinarum in patient ICU9) were
present in the feces of patients who were ultimately discharged
from the hospital. These communities could not be induced to
express virulence against C. elegans even under provocative con-
ditions. In fact, we have recently reported that C. albicans isolated
from patient ICU4 did not respond to phosphate limitation with
enhanced virulence compared to that seen with C. albicans iso-
lated from patients ICU1 and ICU6 (25). The nonvirulent behav-
ior of C. albicans isolated from patient ICU4 was again seen in the
present study. A study in which dynamic and repeated fecal mi-
crobial analysis is coupled to physiologic variables in the host
might more accurately inform outcome measure under the highly
oscillatory conditions of critical illness.
In summary, here we demonstrate that the intestinal micro-
biome in critically ill patients can be considered a “damaged or-
gan” given that its main cellular mass, the normal microbiota, is
disrupted and dominated by pathobiota which may be an ever-
threatening source for disseminating pathogens. The emergence
of ultra-low-diversity pathogen communities and the activation
of virulence in the response to host cues released during physio-
logic stress are characteristic features of this organ in some criti-
cally ill patients. Dynamic assessment of the composition and vir-
ulence potential of the intestinal microbiota or pathobiota over
the course of a critical illness may allow a more calibrated use of
antibiotics or, alternatively, the development of novel strategies to
preserve the core intestinal microbiome when multiple antibiotics
are needed to treat life-threatening extraintestinal infections.
MATERIALS AND METHODS
Stool sample collection. Stool sampling was performed in accordance
with the Institutional Review Board (IRB) protocol approved by Univer-
sity of Chicago. In order to establish baseline normal controls, samples
were collected from five healthy volunteers who were not treated with any
antibiotics for 1 year prior to sample collection. We next consecutively
selected 14 patients admitted to the intensive care units (ICUs) at the
University of Chicago hospitals from whom consent could be obtained for
stool collection. All patients signed consent forms to participate in the
study. The 14 patients represented a diverse group of ICU patients with
various lengths of stay, including those who were resident for less than
10 days (3 of 14 patients), those who were resident for between 20 and
30 days (3 of 14), and those who were resident for 30 days (6 of 14).
When possible, stool samples were collected at several time points during
the ICU course.
Demographic and clinical history. Demographic and clinical histo-
ries of ICU patients, including past medical history, admitting diagnosis,
hospital course, therapy, especially antibiotic therapy, and discharge sum-
mary, were available in the patients’ charts in accordance with the IRB
protocol. Among the 14 ICU patients, 10 were admitted to the ICU for a
period of 20 days or longer. Of these 10 patients, 7 died despite continuous
intensive care. The patients who died all died with signs of severe sepsis,
although there was considerable variability in their comorbidities and
underlying illnesses.
16S rRNA analysis of stool samples. The microbial composition of
stool samples was analyzed by 16S rRNA V4 iTAG amplicon sequencing
of DNA recovered from stool samples. A BiOstic Bacteremia DNA isola-
tion kit from MoBio Laboratories was used to extract DNA. DNA was
analyzed using next-generation Illumina sequencing. Reads containing
low-confidence base calls (phred value, 20) were dropped, and the re-
maining 150-bp-long sequences were clustered into 97%-similarity oper-
ational taxonomic units (OTUs) using QIIME 1.6.0’s pick_otus.py script
with default parameters (36, 37). OTUs composed of fewer than 10 se-
quences were discarded, and the remaining OTUs were assigned taxo-
nomic annotations by searching representative members of each cluster
against the Greengenes 12_10 (38) database using the RDP classifier (39).
Sequencing depth among samples was normalized by rarefaction to 1,200
sequences per sample prior to calculating taxonomic relative abundances.
Microbial-community diversity was calculated for each sample using the
Chao1 alpha diversity metric, as implemented by the QIIME alpha
_rarefaction.py script.
The samples isolated from ICU patients (patients ICU1-1, ICU1-2,
ICU2-1, ICU2-2, ICU3-1, ICU3-2, ICU4-1, ICU4-2, ICU4-3, and
ICU4-4) were independently processed for 16S rRNA analysis at Michi-
gan State University. DNA was extracted from the stool samples using a
PowerSoil DNA isolation kit from MoBio Laboratories following the
manufacturer’s instructions with the exception that Inhibitor Removal
Solution from MoBio’s Ultra-Clean Fecal DNA isolation kit was added to
the PowerBead Tubes along with solution C1. PCR amplification and
purification were similar to those described by Rosenzweig et al. (40). The
amplification and purification procedures differed in that samples were
first amplified for 15 cycles using primers 577f and 927r without bar codes
or adaptors, and then 2 l of each reaction mixture was amplified for 15
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more cycles with primers containing the bar codes and Roche adaptors.
The thermocycler program for the first PCR was 95°C for 3 min and then
15 cycles of 95°C for 45 s, an annealing temperature of 44°C (determined
from optimization experiments) for 45 s, and 72°C for 90 s, followed by
elongation at 72°C for 7 min before the reaction mixture was held at 4°C.
The thermocycler program for the second PCR was 95°C for 3 min and
then 15 cycles of 95°C for 45 s, 56°C for 45 s, and 72°C for 90 s, followed by
elongation at 72°C for 7 min before the reaction mixture was held at 4°C.
Equal mass amounts of the amplicon libraries were mixed and submitted
for sequencing to the Research Technology Support Facility at Michigan
State University.
The sequence results were obtained and processed using the tools on
the Ribosomal Database Project’s Pyrosequencing Pipeline at http://py-
ro.cme.msu.edu/. Initial processing parameters were a forward primer
maximum edit distance of 2, a reverse primer maximum edit distance of 0,
a maximum number of N’s of 0, a minimum read Q score of 20, and a
minimum sequence length of 300. Trimmed sequences averaging 331 bp
were aligned and clustered at a distance of 3%, and the cluster results were
reformatted to be read into R (41) as an OTU table. Representative se-
quences for each OTU were submitted to the RDP Classifier for identifi-
cation and to the Decipher Find Chimeras tool of the University of Wis-
consin—Madison at http://decipher.cee.wisc.edu/ using the Short-
Length Sequences option. OTUs identified as chimeric sequences were
removed from the data. Further analysis was done using the BioDiversityR
(42) package within the R program.
The 16S rRNA analysis of the aliquots of stool samples from the same
patients was performed by the Argonne National Laboratories and Mich-
igan State University with almost identical results, confirming extremely
low diversity of the stool samples from patients ICU1 and ICU4.
Isolation, identification, and antibiotic resistance of cultured mi-
croorganisms. Microbial species were isolated by plating bacterial com-
munities on plates selective for Gram-negative () bacteria (MacConkey
II), for Gram-positive () bacteria (Columbia CNA agar with 5% sheep’s
blood [SB]) (Becton and Dickinson), for Pseudomonas aeruginosa (Pseu-
domonas isolation agar [PIA]), and for fungi (saturated dextrose agar with
chloramphenicol and gentamicin) and on Trypticase soy agar with 5%
sheep blood (TSA II 5% SB) for cultivating fastidious microorganisms.
Gram () bacteria were identified by the use of a Vitek2 system (bioMéri-
eux, Inc., Durham, NC). Gram () bacteria were identified by standard
manual methods. Enterococcus species identification was performed by
the use of a Vitek2 system. A positive germ tube test identified Candida
albicans. Susceptibility testing was performed by testing on a Vitek2 sys-
tem or by disk diffusion. Susceptibility testing of Gram-negative bacilli
was performed by the use of a Vitek2 system or by disk diffusion. Suscep-
tibility testing of MRSA and enterococci was performed by the use of a
Vitek2 system. Susceptibility testing of the other Gram-positive cocci was
performed using a combination of disk diffusion and E test strips. Suscep-
tibility testing ofCandidawas performed using a Sensititre YeastOne MIC
panel (TREK Diagnostic Systems Inc., Cleveland, OH). Susceptibility re-
sults were interpreted using Clinical and Laboratory Standards Institute
(CLSI) guidelines.
Caenorhabditis elegans killing assay. The 2-member whole commu-
nities were compared to their individual members for killing capacity by
assessing mortality of C. elegans transferred into liquid microbial cultures
as in our previously described experiments (15, 17). Nematodes of
C. elegans N2 provided by the Caenorhabditis Genetic Center (CGC),
University of Minnesota, were used in all experiments. Nematodes were
prepared as follows: synchronized nematodes (larval stage 4 [L4] to young
adults) were transferred fromE. coliOP 50 stock plates onto plain agarized
plates, followed by a second transfer onto new plain agarized plates (Fal-
con) (60-mm diameter). Next, 1 ml of 100 g/ml kanamycin was poured
on the agar surface; after 3 h, worms were retransferred into experimental
microbial cultures.
Microbial cultures were prepared as follows: microbes from frozen
individual stocks were plated on Trypticase soy broth (TSB) solid plates
and incubated at 37°C overnight. Cells grown overnight were used to
prepare stock microbial suspensions in 0.1 TY liquid media (tryptone,
1 g/liter; yeast extract, 0.5 g/liter, potassium phosphate buffer, 0.1 mM
[pH 6.0]) (referred to here as 0.1TY) to reach an absorbance of 1.0 at an
optical density of 600 (OD600). Stock microbial suspensions were diluted
in fresh 0.1 TY to an OD600 of 0.1 to prepare individual microbial cul-
tures. To prepare community cultures, the respective stocks were mixed to
reach an OD600 of 0.1 for each individual microbe in the mixture. In the
experiments performed with Pi-PEG15-20, the stock microbial suspen-
sions and final microbial cultures were prepared in 0.1 TY supple-
mented with 10% Pi-PEG15-20, and the pH was adjusted with KOH to
that of 0.1TY (pH 5.8). Microbial cultures were grown individually and
as a mixture for 5 h at 37°C with shaking at 200 rpm. Then, 2 ml of the
microbial culture was poured into a 35-mm-diameter empty sterile plate
and adjusted to room temperature, and 5 to 10 worms were transferred
into each plate. For each variant, 3 to 5 plates were prepared. C. elegans
were fed on microbial cultures for up to 72 h under static conditions at
room temperature (~23°C). The mortality of worms was followed dy-
namically.
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